SPARC in green on receiving approval to raise funds up to Rs 250 crore

14 May 2015 Evaluate

SPARC is currently trading at Rs. 386.25, up by 5.00 points or 1.31% from its previous closing of Rs. 381.25 on the BSE.

The scrip opened at Rs. 380.95 and has touched a high and low of Rs. 391.85 and Rs. 374.85 respectively. So far 1,43,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 598.00 on 10-Mar-2015 and a 52 week low of Rs. 151.00 on 19-May-2014.

Last one week high and low of the scrip stood at Rs. 400.75 and Rs. 374.85 respectively. The current market cap of the company is Rs. 9,145.00 crore.

The promoters holding in the company stood at 67.13% while Institutions and Non-Institutions held 6.99% and 25.88% respectively.

Sun Pharma Advanced Research Company (SPARC) has received an approval for further issuance of equity shares of Re 1 each of the company, on rights basis to the shareholders of the company on such ratio and at such price and premium as may be decided in consultation with the Lead Managers to the proposed rights issue, so that the funds raised by way of right issue of shares is not more than Rs 250 crore. The board of directors at their meeting held on May 12, 2015 has approved for the same.

Sun Pharma Advanced Research Company (SPARC) is an international pharmaceutical company engaged in research and development of drugs and delivery systems.



Sun Pharma Adv. Res Share Price

205.00 14.60 (7.67%)
22-Nov-2024 12:25 View Price Chart
Peers
Company Name CMP
Syngene Internation. 862.70
Sagility India 28.18
AGS Transact Tech 81.09
Just Dial 1071.00
Krystal Integrated 640.80
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.